ZALASTA 5 mg, orodispersible tablet 28 tablets
Active ingredients: Olanzapine
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZALASTA 5 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium polyamide PVC de 28 comprimé(s)
- Marketing authorisation holder
- KRKA (SLOVENIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Sept 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68722386CIP72241529CIP133400922415291Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OLANZAPINEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.